Biologics and small molecules for patients with concomitant alopecia areata and vitiligo: A review
Int J Dermatol
.
2024 Dec 11.
doi: 10.1111/ijd.17595.
Online ahead of print.
Authors
Eric McMullen
1
,
Shahnawaz Towheed
2
,
Dea Metko
2
,
Shanti Mehta
3
,
Shireen Dumont
4
,
Cathryn Sibbald
1
5
,
Jeffrey Donovan
6
7
Affiliations
1
Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.
2
Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.
3
Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
4
Division of Dermatology and Venereology, Geneva University Hospitals, Geneva, Switzerland.
5
Division of Dermatology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
6
Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada.
7
Donovan Hair Clinic, Whistler, BC, Canada.
PMID:
39659252
DOI:
10.1111/ijd.17595
No abstract available
Keywords:
JAK inhibitor; alopecia areata; biologic; small molecule; vitiligo.
Publication types
Letter